HomeNewsBusinessEconomyCOVID-19 makes money more scarce for MP's small farmers
Trending Topics

COVID-19 makes money more scarce for MP's small farmers

On September 19, the traders of the APMC had announced a five-day bandh to protest against the inaction of the government regarding the rising cases of coronavirus. As farmers are unable to sell their produce owing to indefinite strike, most of them are forced to sell their yield for lower prices.

October 26, 2020 / 15:49 IST
Story continues below Advertisement

Since September 25, the employees of the Agricultural Produce Market Committee (APMC) yard in Neemuch district of Madhya Pradesh are on a strike to protest against the Model Market Act. Small farmers of the district have been badly affected because of the strike and COVID-19.

On September 19, the traders of the APMC had announced a five-day bandh to protest against the inaction of the government regarding the rising cases of coronavirus.

Story continues below Advertisement

The mandi had started procurement only two days before this, and only a few farmers had been able to sell their produce. As farmers are unable to sell their produce owing to indefinite strike from September 25, most of them are forced to sell their yield for lower prices. Some farmers claim that they have sold their produce at a quarter of the cost incurred.

As farmers get ready for the next sowing season, they need money to cover the costs, and thus, are forced to sell their yield to local traders. They are also unable to get loans as moneylenders are charging high interests. Farmers say they have exhausted almost all of their savings.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show